Cytek Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CTKB?
Owner Type	Number of Shares	Ownership Percentage
State or Government	67,499	0.0524%
VC/PE Firms	6,657,030	5.17%
Individual Insiders	11,499,997	8.93%
General Public	41,599,455	32.3%
Institutions	68,986,633	53.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 60.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.4%	BlackRock, Inc.	18,492,291	US$118.9m	8.33%	no data
9.14%	The Vanguard Group, Inc.	11,778,054	US$75.7m	0.27%	no data
7.37%	Brown Capital Management, LLC	9,493,474	US$61.0m	-16.6%	0.78%
5.17%	Hillhouse Investment Management, Ltd.	6,657,030	US$42.8m	0%	0.38%
4.67%	Ming Yan	6,018,322	US$38.7m	0.19%	no data
4.03%	Wenbin Jiang	5,187,638	US$33.4m	0.6%	no data
3.24%	State Street Global Advisors, Inc.	4,167,501	US$26.8m	4.89%	no data
2.07%	Geode Capital Management, LLC	2,668,004	US$17.2m	3.46%	no data
1.62%	New York State Common Retirement Fund	2,088,390	US$13.4m	-29.2%	0.02%
1.56%	Wellington Management Group LLP	2,007,139	US$12.9m	-6.02%	no data
1.22%	Dimensional Fund Advisors LP	1,567,825	US$10.1m	7.01%	no data
0.83%	Northern Trust Global Investments	1,067,063	US$6.9m	-1.69%	no data
0.8%	Charles Schwab Investment Management, Inc.	1,030,962	US$6.6m	12.3%	no data
0.56%	BNY Asset Management	719,044	US$4.6m	-10.6%	no data
0.55%	Morgan Stanley, Investment Banking and Brokerage Investments	712,842	US$4.6m	44%	no data
0.51%	Goldman Sachs Asset Management, L.P.	656,668	US$4.2m	2.21%	no data
0.48%	Connor, Clark & Lunn Investment Management Ltd.	615,630	US$4.0m	-2.51%	0.02%
0.45%	Fidelity International Ltd	573,600	US$3.7m	0%	no data
0.4%	Impresa Management LLC	517,790	US$3.3m	0%	1.81%
0.4%	JP Morgan Asset Management	517,530	US$3.3m	-1.22%	no data
0.39%	Principal Global Investors, LLC	503,172	US$3.2m	4.8%	no data
0.28%	Goldman Sachs Group, Investment Banking and Securities Investments	366,076	US$2.4m	-48.8%	no data
0.27%	Eaton Vance Management	354,173	US$2.3m	-10.8%	no data
0.27%	Columbia Management Investment Advisers, LLC	353,441	US$2.3m	32.1%	no data
0.26%	Algert Global LLC	329,375	US$2.1m	11.6%	0.05%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/18 23:20
End of Day Share Price	2024/12/18 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cytek Biosciences, Inc. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kyle Mikson	Canaccord Genuity
Matthew Sykes	Goldman Sachs
Tejas Savant	Morgan Stanley